Rising Stars in Hematologic Malignancies 2021

Recognising the future leaders of oncology is fundamental to safeguarding tomorrow's driving force in innovation.

This collection will showcase the high-quality work of internationally recognized researchers in the early stages of their careers. We aim to highlight research by leading scientists of the future across the entire breadth of Hematologic Malignancies, and present advances in theory, experiment and methodology with applications to compelling problems.

Submissions to this Research Topic must fit an eligibility criteria. Please contact the Editorial Office at oncology@frontiersin.org with your CV and manuscript abstract.

While future innovations in Hematologic Malignancies are yet to be discovered, this Research Topic will give us a hint at whom to follow.

Manuscripts consisting solely of bioinformatics, computational analysis, or predictions of public databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) will not be accepted in Frontiers in Oncology.

Keywords: rising stars, hematological oncology

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.